Core Viewpoint - The company plans to acquire 100% equity of Yijie Medical for a total transaction price of 334.85 million yuan, aiming to expand its product offerings in the neuro-interventional medical device sector [1] Group 1: Acquisition Details - The acquisition will be executed through a combination of share issuance and cash payment [1] - Yijie Medical specializes in the research, design, and sales of medical devices in the neuro-interventional field, including treatment and access products [1] Group 2: Market Position and Synergies - Yijie Medical has established partnerships with over 200 distributors and its products are available in more than 200 top-tier hospitals across the country [1] - The target company's primary customers are neurology departments in hospitals, which overlap significantly with the company's existing customer base [1] - Post-acquisition, the company aims to leverage the combined distribution channels and marketing systems to enhance sales efficiency in neurology departments [1] Group 3: Technological and R&D Advantages - The company possesses extensive R&D experience and a strong technical foundation in medical devices for neurology [1] - The acquisition will enable the company to extend its expertise in biocomposite materials from the implantation field to the interventional field, enhancing its R&D capabilities in interventional biomaterials [1]
迈普医学：拟3.35亿元购买易介医疗100%股权